novo nordisk semaglutide clinical trials said on Tuesday its triple agonist UBT251 of the receptors for GLP-1, GIP and glucagon, jointly developed with United Biotechnology, achieved a statistically significant mean weight loss of up to Oral semaglutide (Rybelsus®) receives FDA

All incubation steps carried out at 4 C or RT were done with gentle shaking

Jul 23, 2026Retatrutide reported two more successful Phase 3 trials 20.8% weight loss in people with type 2 diabetes and 22.6% in people with severe obesity and heart disease and Lilly pushed its FDA submission to early 2027

In rat fistulas studies, creation of the fistulas by anastomoses between the different tissues, accurately provides the defined defect in each of the tissues

High energy density lithium battery systems: from key cathode materials to pouch cell design

In another randomized, double-blind study, three-month acetyl-l-carnitine supplementation provided statistically significant support for mental function, including memory and attention, compared to placebo